HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients-Reference-Cited by-同舟云学术

HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients

Published:2014-03-13 Issue:5 Volume:28 Page:739-743
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Landay Alan,Golub Elizabeth T.,Desai Seema,Zhang Jinbing,Winkelman Val,Anastos Kathryn,Durkin Helen,Young Mary,Villacres Maria C.,Greenblatt Ruth M.,Norris Philip J.,Busch Michael P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference17 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.;Pallela;N Engl J Med,1998

2. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.;Palmer;Proc Natl Acad Sci U S A,2008

3. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.;Neuhaus;AIDS,2010

4. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.;Deeks;BMJ,2009

5. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.;Deeks;Immunity,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection;International Journal of Molecular Sciences;2024-05-29

2. Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy;Journal of Clinical Microbiology;2020-11-18

3. Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy;Journal of Clinical Microbiology;2020-11-18

4. Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma;AIDS;2020-01-01

5. HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen;Journal of Clinical Virology;2018-12